Aggressive type giant cells central tumor. Treated with interferon alpha 2ª profiled. Report of a case

Authors

  • Carlos Alberto Gómez Rivas Hospital General de Zona No. 1 de Aguascalientes, IMSS. Aguascalientes, México.
  • Dailyn Rodríguez Rodríguez Servicio de Cirugía Oral y Maxilofacial, Hospital Regional General Ignacio Zaragoza, ISSSTE. Ciudad de México, México.

DOI:

https://doi.org/10.20453/reh.v31i3.4052

Abstract

The central giant cell lesion is a benign, localized, but sometimes very aggressive, osteolytic-type maxillary tumor proliferation. Most of the cases are asymptomatic, however, some may present paresthesia, pain, bleeding, loss of dental organs and sometimes nasal obstruction. Aggressive or malignant variants can grow faster and cause pain or paresthesia. We present an 8-year-old female patient with an aggressive central giant cell lesion. Antiangiogenic therapy with interferon alpha 2 was performed after surgery, obtaining satisfactory results. This therapy allows us to avoid radical surgeries that could produce a poor functional and aesthetic prognosis.

Published

2021-10-18

How to Cite

1.
Gómez Rivas CA, Rodríguez Rodríguez D. Aggressive type giant cells central tumor. Treated with interferon alpha 2ª profiled. Report of a case. Rev Estomatol Herediana [Internet]. 2021 Oct. 18 [cited 2024 Jul. 3];31(3):216-20. Available from: https://revistas.upch.edu.pe/index.php/REH/article/view/4052

Issue

Section

CASE REPORTS